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This Working Paper has been written in the context of the 1998-1999 European Forum 
programme on Recasting the European Welfare State: Options, Constraints, Actors, 
directed by Professors Maurizio Ferrera (Universities of Pavia and Bocconi, Milano) and 
Martin Rhodes (Robert Schuman Centre).
Adopting a broad, long-term and comparative perspective, the Forum will aim to:
• scrutinize the complex web of social, economic and political challenges to contemporary 
European welfare states;
• identify the various options for, and constraints on institutional reform;
• discuss the role of the various actors in promoting or hindering this reform at the national, 
sub-national and supra-national level;
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A b s tr a c t
Welfare state policies in the health sector centred on medical care and cost containment. The 
AIDS epidemic challenged the central position of the medical model and introduced new 
public policies at the periphery of the welfare state, in the field of prevention and public 
health management.
The article compares the evolution of national policy responses in several European 
countries. Each of them combined the general principles of the fight against the epidemic, 
conceived in international forums and based on educational strategies aiming at behavoural 
changes, with path dependencies at various levels, especially the institutional structures of 
health systems and the public/private borderline. Both determine the potential field for public 
health policies and condition the capacity of implementation in each national context. The 
importance of "private life" issues in the epidemic introduced cultural phenomena into official 
health policies, and provided an occasion to observe the interaction of cultural and 
institutional factors in health management. The general principals of AIDS policies were 
revised as implementation progressed, shifting from an initial focus on the protection of 
anonymity and privacy towards the improvement of public health management and the 
reinforcement of its institutional support.
The epidemic posed a threefold challenge for European health systems: co-ordination 
across different policy fields, the extension of educational strategies to socially marginalised 
groups, and beneficiary participation which introduced non medical dimensions as well as 
pressure for the legal protection of patients and the control of research developments. All 
called into question the corporatist mode of health management, the institutional 
fragmentation of health policy networks and the dominant influence of the medical profession 
over health issues. In all these respects, AIDS policies have contributed to the general reform 
trends in European health systems. Future perspectives indicate that the responsibility of 
public authorities will not diminuish but grow with therapeutic progress.
This text is a revised version of a paper presented at the European Forum Conference on 
“Beyond the Health Care State: Institutional Innovations and New Priorities in Access, 
Coverage and Provision of Health Services”, 26-27 February 1999, at the European 
University Institute. The conference was organised by Maurizio Ferrera (University of Pavia), 
Ana Guillen (University of Oviedo) and August Oesterle (Vienna University of Economics 





















































































































































































Policy studies in the health sector have generally centred on the relationships 
between the medical profession, the financing institutions and the state 
authorities. International comparison developed as growing health expenditure 
met with limited economic growth and as European welfare states were 
confronted with the common problem of cost containment. The cost problem 
provided the main intellectual framework for comparative studies of health 
systems and policies. This article focuses on the dynamics of change at the 
periphery of the medical systems, in the field of public health and risk 
management. It analyses how European health systems reacted to the 
unexpected challenges of the AIDS epidemic which constituted one of the most 
important public health issues of this century.
The case is interesting in many respects and significant for future 
developments in European health systems. It calls into question the central role 
of the medical model and economic factors. Globalisation trends in this case are 
due to international dimensions in risk transmission and to international 
movements of solidarity. Control and management of the epidemic call for 
reinforced public intervention and state responsibility. New financial ressources 
are needed for research, care, social support, prevention and public health 
administration. The growing number of people living with HIV-infection calls 
for comprehensive coverage linking acute medical care and service provision 
for the chronically ill and physically handicapped. The connection of the risk 
with sexuality, marginal behaviour and blood donation links public health 
policies with social and cultural phenomena, and thus introduces cultural 
dimensions into health policy analysis. The AIDS case facilitates the 
observation of how different health systems respond to a similar problem, and 
wether and how they learn to adapt their institutional organisation to new 
norms, constraints and priorities. The comparative analysis contributes to the 
understanding of health management in Europe.
This article first analyses the challenges of the epidemic to European 
health systems and their responses to the new problem. It then examines the two 
central difficulties health policy makers had to face, the public-private 
borderline on the one hand, and the introduction of public health dimensions 
into previous policies on the other. The last chapter shows how AIDS bom 
innovations are linked with the general reform tendencies in European health 
systems, and how the public health policies connect with cost containment 
strategies.
THE CHALLENGE OF AIDS
The unexpected arrival of a new public health risk confronted health systems 



























































































have spoken on the subject with the required legitimacy. The way risk-alarm 
was channelled through the different health systems provides an insight into 
their functioning and priorities. It indicates the specific responses to public 
health issues.
The first European AIDS case was discovered in Paris in June 1981, by a 
hospital doctor who diagnosed the symptoms in a patient just after he had read 
the very first article published by the US Center for Disease Control1. He set up 
an informal group of doctors and researchers, in order to find more patients, 
initiate research and ascertain whether the first patients were isolated cases or 
the indicator of an epidemic. The initial expert group remained informal, 
without institutional support apart from a modest link with the General 
Department of Health, the weakest part of the Health Ministry. In Germany, a 
nurse warned the gay organisations and the Health Department of the City of 
Berlin, to obtain social and psychological support for the first patients. The 
City’s health authorities informed the federal authorities who invited a 
delegation from the United States in order to receive first hand information. 
Once convinced of the risk, they initiated a consultation structure between the 
health authorities, medical specialists and representatives of the gay 
organisations, with the aim of establishing a diagnosis on the German situation 
and launch prevention strategies among homosexual men. In Britain, a similar 
bottom-up process channelled the information from London urinary clinics 
receiving the first patients up to the top level of the National Health Service 
(NHS), whose executives informed the Government and the medical authorities. 
After a visit to the United States, the Secretary of State for Health confirmed the 
need for rapid action.
In Britain, Germany, Switzerland and the Northern European countries, 
institutional channels favoured a relatively rapid awareness of the public health 
risk and the govemement took up the problem (Day and Klein, 1989; Kirp and 
Bayer, 1992; Steffen, 1996). In France, scientific interests prevailed over risk 
awareness. Although the virus was isolated in March 1983 by researchers from 
the Institute Pasteur in Paris, medical authorities and the Government only 
reacted when the same discovery was announced by an American team (Seytre, 
1993). AIDS entered the political agenda in France when national interests in 
the fields of science and industry were threatened. In Southern Europe, 
especially in Spain, Portugal and Greece, AIDS received no notable public 
attention until the early nineties, when the many deaths of drug addicts could no 
longer be ignored.
The AIDS challenge developed simultaneously in three directions: 
research, care and prevention. Scientific investment aimed at a vaccine and 
curative treatment. In the main disciplines concerned with AIDS, notably 




























































































questions. Previously neglected fields were developed, notably retro-virology. 
Infectiology became a noble discipline again. Two particularly under-developed 
fields were scientifically structured: public health research in the field of 
sexuality, and social science research in the field of coping with illness. Clinical 
research reinforced collaboration between hospitals, public research agencies 
and the private pharmaceutical industry, on national as well as international 
levels. The AIDS challenge introduced multi-disciplinary co-ordination into 
health related research. In France, all public AIDS research was placed under 
the authority of the ANRS (Agence Française de Recherche sur le Sida), 
created in 1988. Recently, the agency’s activities have been widened to cover 
other transmittable diseases with priority for hepatitis C. The extension of the 
AIDS model to infectious and sexually transmittable disease has became an 
international world wide trend.
For the provision of medical care, AIDS patients and doctors were backed 
by the welfare state. In European health systems, access to adequate care was 
granted by the compulsory health insurance. The major difficulty was to co­
ordinate hospital care, ambulatory care and social services. Elsewhere, AIDS 
represents an acute problem of care provision which depends either on 
exceptional procedures, like the mobilisation of the AIDS organisations in the 
United States, or on international assistance and funding, as illustrated by the 
Eastern European countries (Steffen, 1999b) and the Brazilian anti-AIDS plan 
which was carried out under the auspices of the World Bank.
Beyond the Scope of Medical Treatment
In European welfare states, AIDS management differed mainly in the ways 
prevention policies were conceived and implemented. The key problem was 
indeed the absence of a curative treatment. After the thirty glorious years of 
antibiotic use, a transmittable disease with fatal consequences was spreading 
without any medication being available to stop it. The limits of medical art had 
to be made up for by preventive measures based on social intervention 
strategies, aiming at long term behavioural changes. This in turn led to political 
controversy. Public policies were introduced into the field of sexuality and 
health goals into drug policies. Information systems had to be set up to monitor 
the epidemic, for epidemiological purposes and hospital planning. The 
weakness of expert capacity in public health became evident as did the 
necessity to construct efficient statistical tools. Controversy arose over the type 
of declaration systems needed and over the guarantees of confidentiality. The 
AIDS case revealed the potential extent of controversy over health intervention 
when based on non-medical tools, in sharp contrast to the consensus on the 




























































































The second problem concerned the capacity of co-ordination, at 
governmental as well as professional levels. Care and prevention strategies had 
to be co-ordinated over a wide range of policy sectors with no previous links: 
the prevention of sexually transmittable diseases (STD), health oriented sexual 
education, care for drug addicts and prisoners, specific counselling and medical 
monitoring for HIV-infected mothers, the reinforcement of safety standards in 
hospitals, blood and organ donation systems and parts of the pharmaceutical 
industry. Only a strong commitment to public health and a well organised health 
administration could guide such comprehensive policies which contrasted with 
the individual treatment patterns of medical art and the fragmented structure of 
services and policy networks in most countries.
The third strategic problem concerned public health management. No 
reforms had modernised this field, which had been neglected during the 
extensive development of medical services. Belief in victory over transmittable 
disease had driven public health away from medical and political attention. The 
traditional intervention models were based on legislation on infectious and 
sexually transmittable disease, including case reporting, compulsory treatment, 
contact tracing, and in certain cases isolation of disease carriers. These methods 
appeared unsuitable for AIDS where the active collaboration of the people at 
risk was needed. When the antibody test became available (1985), public health 
specialists as well as gay militants argued that the application of traditional 
procedures would lead to breaches of civil rights and private life. It was argued 
that AIDS sufferers would avoid attending medical services to escape social 
risks, especially as no effective treatment could be offered to them. These 
arguments subordinating preventive approaches to their curative interest were 
particularly evident in France. The central question concerned the interest and 
dangers of systematic screening in particular risk groups. The "exceptional 
AIDS coalition" between public health experts, clinicians and gay activists gave 
the answer to that question (Bayer, 1991). It ensured that AIDS was taken out of 
the field of public health regulations and replaced by a policy of voluntary 
testing, voluntary partner information and medical confidentiality. Lack of 
therapeutic benefits pleaded for subtle intervention strategies based on 
education and participation.
The Twofold Epidemic
The epidemic went through two distinct phases. Initially, it was perceived as an 
interesting medical and social issue. AIDS appeared as an illness afflicting an 
international elite of eccentric people. The respect for the individual, privacy 
and human rights occupied the front line of AIDS mobilisation. The picture 
changed as the epidemic spread in underprivileged social classes, drug addicts 
and ethnic minorities less used to the respect of their individual rights. AIDS 



























































































migration, prostitution and sex tourism. By the end of the eighties, the epidemic 
had turned out to be an extremely serious public health problem.
Health authorities were faced with the challenge of providing 
comprehensive care and prevention strategies to marginalised populations. The 
principles of AIDS management which were elaborated during the 
"exceptionalist" period and conceived for middle class gay communities, had to 
be implemented in social environments where conditions were very different. 
The new clients did not have an equal capacity of collaborating with public 
authorities and promoting education. The professionals were confronted with 
the challenge of bridging the social gap and generalising the new public health 
approach. New modes of intervention had to be developed, based on proximity 
strategies, long term follow-up and free provision of services and equipment 
such as medicine, condoms, syringes and sterilising equipment. The practical 
means of prevention and care were in fact more similar to social work than to 
the medical model.
The presence of AIDS activists, especially the ACT-UP groups, 
contributed to maintaining political pressure. Their impact, however, proved 
more efficient in obtaining medical care than in the field of prevention. This 
was illustrated when the new multi-therapies appeared in the mid-nineties and 
allowed mortality rates to be curbed for the first time. In several countries, 
health authorities intended to limit access during the first year, arguing that a 
period of observation was needed in respect to long term consequences. These 
arguments were swept away by a storm of protest and, finally, free access was 
granted for all HIV carriers who could support the new treatment. Cost 
considerations were thrust aside with the argument that the new medication 
economised in hospital expenditure.
The issue reappeared at international level as a North/South problem. In 
1997, controversy arose between the international agencies responsible for 
economic and social development. They were divided over the use of 
international funding either for medical care or primary prevention and 
economic development. A project of "international therapeutic solidarity", 
initiated by European activists and the French government with support from 
the European Union aimed at free provision of the new medication to the AIDS 
patients in the Third World . The project remained of limited impact, since it 
depended on the negotiations over price policies with the international 
pharmaceutical industry, funding policies with the international development 
agencies and scientific tests to evaluate the most efficient strategies for 
targeting specific populations. The AIDS epidemic confronted national as well 
as international health policy systems with the challenge of evaluating the 





























































































European health systems faced the new challenges with different inputs and 
outcomes. Two decades after the outbreak of the epidemic, HIV occurrence is 
up to six times higher in France than in Great Britain. France, which had the 
greatest number of cases in the European Union for many years, was finally 
overtaken by the Southern European countries struck with massive HIV 
transmission related to intravenous drug use (IDU). The latter had greater 
difficulty in responding to the challenge for several reasons inside and outside 
the health systems. One specific reason was related to the mismatch between the 
dominant prevention model, catering for homosexual males, and the IDU- 
profile of the Mediterranean epidemic. The following tables show the striking 
differences in policy outcomes, between countries which have a comparable 




























































































Table 1 . National profiles. Origins of virus transmission














France 45 .1 2 3 .6 1.3 19 .9 4.7 5.4
Italy 13.9 6 1 .8 2.0 12.3 1.6 8.4
Germany 6 5 .5 14.2 0.9 8.5 4.5 6.4
Great-Britain 6 8 .4 6.5 1.8 17.4 4.8 1.1
Spain 14.1 65 .1 1.6 12.4 2.0 4.8
Source: WHO-EC Collaborating Centre on AIDS, Paris.
Table 2 . Extension of the epidemic
Spain France Italy Germany G.B.
Reported AIDS cases, 
totalled at 31.12.1998 and 
adjusted for declaration 
delays
52,216 48,676 42,760 17,836 15,675
Estimation of HIV-infected 
persons, alive, 31.12.1995*
- total number











Source: WHO-EC Collaborating Centre on AIDS, Paris.
*Figures have deliberately not been actualised. Until 1995, the epidemiological data 
reflected the history of the epidemic and the policy responses to it. Since then, the 
new multi-therapies introduced a new factor determined by access to the new 
treatment and its strict observation by the beneficiaries.
Table 3 . Incidence rates of declared AIDS cases per million inhabitants, 
by year of diagnosis, adjusted for reporting delays
1992 1995 1998
Sweden 14.7 21.9 6.2
Germany 22.5 20.8 10.6
Great Britain 27.2 29.9 13,6
France 88.2 88.2 30.0
Italy 74.6 99.0 40.9
Spain 125.5 173.2 93.3




























































































Unequal success or failure in fighting the epidemic raises general questions 
concerning the way national health systems respond to identical issues, and the 
effectiveness of international policy solutions when implemented in different 
national contexts. What common features in Sweden, Great-Britain and 
Germany explain why they have been more successful in fighting the epidemic 
and what in Spain, Italy and France explains their failure? Why was the French 
scientific advance not translated into corresponding policy achievements, with 
the help of the well developed French public administration and strong 
executive? The factors and classifications usually referred to in welfare state 
literature and health policy analysis proved of little relevance to the question. 
The public or private status of management structures and care delivery, which 
bring together France and Germany for their public-private mix on the one 
hand, Italy, Great-Britain and Sweden for their public systems on the other, had 
no influence. Similar degrees of centralisation or decentralisation even 
produced opposite effects. In Great Britain, the institutional structures of the 
National Health Service (NHS) provided favourable conditions for rapid public 
intervention and co-ordination. In France, on the contrary, the high level of 
centralisation made necessary changes extremely difficult due to lack of 
consensus between the national policy makers. In 1987, AIDS policies were 
placed under the exclusive control of the central state government, as the 
policies concerning drug addiction had been in 1970. The legally prescribed 
centralisation hindered local innovation. In Germany, the régionalisation of 
health policies and the decentralisation of implementation structures favoured 
innovation and experimentation at the level of the Lander and municipalities. 
This in turn helped to overcome resistance from vested interests at the national 
level. In Italy on the contrary, a comparative degree of decentralisation led to 
lack of co-ordination, unequal implementation and conflict between the 
different levels of health administration.
A major difference between the countries was the attitude of the medical 
profession towards the public health risk. Everywhere, doctors played an 
important part in health policy. Their most central position in France, however, 
is exceptional in the international comparison (Jobert and Steffen, 1994). The 
lack of interest of the French medical elite for the public health problem had 
crucial consequences. It legitimised politicians and intellectuals in their strategy 
of risk minimisation and enabled them to politicise the issue.
In Italy, on the contrary, a group of medical professors, specialists in 
infectious disease, lobbied the government and obtained the creation of the 
National AIDS Commission which conceived the Italian public policy and the 
national anti-AIDS plan, voted as a law in 1990. The case illustrated the 
important role university professors play in the modernisation of Italian public 
policies (Regonini and Giuliani, 1994). Implementation however proved 




























































































alliance at the central level between the administration, the government and the 
interested clinicians. The regions brought the issue before the constitutional law 
court. Private organisations, which played an important role in caring for drug 
addicts, contested the resource allocation, up to 85% reserved for public 
hospitals, and the little attention given to the private sector and the psycho­
social services it operated. In 1993, most of the public funding had not reached 
its destination (Calvaruso, 1993). It had been diverted to other uses, especially 
to pharmaceutical consumption. Such "redistribution", including clientelist 
politics and corruption3, form part of the still "immature welfare states of 
Southern Europe" (Ferrera, 1996). The Italian case showed how established 
policy networks resisted AIDS exceptionalism and urgency.
In Great-Britain, public health specialists pushed the reluctant Thatcher 
Government into action, with the threat that the epidemic would absorb the 
entire health budget if it was not stopped in time (Street and Weale, 1992). In 
the British system, the institutional structure of the NHS and the political level 
of decision making are linked by the position of the "Chief Medical Officer", an 
independent person whose role is to advise the Minister of Health. During the 
early AIDS years, the position was held by an epidemiologist, whilst practical 
measures were elaborated under the leadership of a clinical specialist in 
sexually transmittable disease. The combined approach of institutional and 
medical management of public health resulted in an efficient model for AIDS 
prevention. Great Britain succeeded in confining the disease within the initial 
risk population.
In Germany, politicians made the strategic choices. Like all regional 
ministries in the Federal Republic, the health ministers have the "Permanent 
Conference of Health Ministers" as a standing working structure. It brings 
together the ministers and their close collaborators from all Lander, from the 
right as well as from the left wing parties according to the majorities in regional 
parliaments. This forum enables them to discuss priorities and co-ordinate 
policies. The health ministers declared AIDS a public health problem requiring 
the means of a national public policy. They drew up the compromises on 
controversial subjects and mobilised the public health agencies under their 
authority. Reluctant local or regional administrations were officially encouraged 
to implement the new prevention policies.
The institutionalisation of AIDS policies clearly followed national 
patterns. The high level of initiative of the British Department of Health and the 
NHS officials corresponded to previous reforms in Britain (Hayward and Klein, 
1994). The capacity of the German politicians to reform health policies and the 
importance of the regional level in this process have been documented in 
historical analyses as well as in cost containment (Jobert and Steffen, 1994). 




























































































Germany and Great-Britain, however, institutional resources and processes 
compensated for the internal medical hierarchy. France and Italy lacked such 
adequate institutional support. Furthermore, in Britain and Germany, AIDS 
policies benefited from an explicit political consensus. The new public health 
policies were legitimised by Parliament, they were evaluated and re-examined 
by parliamentary commissions, from 1986 to 1990. In Italy, the role of 
parliament was limited to voting a law, which was poorly implemented, and the 
French parliament was deliberately excluded from the issue.
PUBLIC HEALTH AND UNCERTAIN BORDERLINES
AIDS prevention confronted health systems with conflict resolution involving a 
larger polity than the traditional partners of the medical care system. The use of 
the antibody test, the public promotion of condoms, the provision of clean 
injection equipment and methadone for IDU addicts, blood donor screening and 
protection of health workers from the risk of infection, all called into question 
existing legislation, ethical beliefs and professional paradigms. Unlike cost 
control policies which confronted identified parties defending precise interests, 
the public health strategies provoked conflicts with moving affinities and 
multiple environments.
The Antibody Test
Two types of arguments initiated demands of systematic screening, in specific 
populations or situations: medico-professional arguments aiming at
epidemiological surveillance and protecting health professionals and patients 
from the risk of contamination during hospitalisation on the one hand and, on 
the other, socio-political arguments aimed at avoiding contact with infected 
people in normal life situations like school attendance, sports activities or 
sexual relationships, and in particular circumstances such as accidents and 
physical aggression involving drug addicts or prison inmates. The screening 
issue was central because of interests outside the health sphere. T̂ est results 
could be used by insurance companies, employers or housing owners. The 
potential social risks excluded compulsory screening from the range of policy 
tools. The professional risk was therefore met by educational strategies based 
on the respect of the general rules of hygiene, the reinforcement of security 
norms and controls and the provision of specific training programmes as well as 
single-use equipment.
The international principal of voluntary testing was adopted by all 
European countries, although not always strictly observed. Sweden made an 
exception by updating its traditional methods of public health surveillance and 




























































































compromise. HIV-antibody tests were "systematically proposed" in a growing 
number of situations such as pregnancy, pre-marriage medical examinations, 
artificial inseminations, drug abuse and medical consultations. This policy 
combined the protection of marginal groups from compulsory screening with 
the possibility of testing growing parts of the population.
The screening controversy illustrated the sensitivity of the respective 
health systems to general political debates and their ability to impose public 
health references. In Great Britain, the screening debate remained limited to 
epidemiologists, divided over the usefulness of systematic testing as a scientific 
means to monitor the epidemic. In Italy, AIDS intervention started with the 
systematic screening of hospital patients, drug addicts and prison inmates. The 
internationally proscribed method provided the Italian authorities with a precise 
picture of the domestic epidemic related to IDU, and very little to 
homosexuality. When the National AIDS Commission was operational, its 
medical experts took up the screening issue and set up a policy of voluntary 
testing for the health professionals and the Ministry of Justice, which was 
responsible for prison administration. Outside the commission, the issue raised 
little public debate. Social and political bases for AIDS mobilisation were 
lacking in Italian society (Moss, 1990). Even the controversy around the 
haemophiliac issue remained limited.
In Germany, open conflict arose inside the conservative alliance in power 
at federal government level. The Bavarian branch of the Christian Democrats 
(Christliche Soziale Union, CSU) demonstrated its independence by taking 
advantage of the regional authority over health policies. Bavaria applied the 
existing regulations on epidemics and transmittable disease to AIDS, although 
the option had been overruled by the Federal Health Minister and the Health 
Ministers’ Conference. Candidates for public appointment, foreigners wanting 
to settle in Bavaria and prostitutes were HIV-tested. Homosexual men however 
were not concerned since the legal rules did not include such a category. The 
issue entailed passionate debates between specialists on constitutional and 
administrative law as well as court procedures to clarify the institutional 
authority. The conflict subsided after the 1986 general election which renewed 
the conservative alliance in the Federal Parliament. The newly elected 
parliament engaged in an active AIDS policy with a four-year emergency 
programme (1986-90) voted by all parties including the CSU, based on the 
educational approach in collaboration with the AIDS organisations.
In France also, the epidemic served electoral politics. The AIDS years 
coincided with the unprecedented "cohabitation" between a President of the 
Republic and a parliamentary majority from opposed parties. Electoral 
competition between the Right and the Left intensified and focused on the 




























































































AIDS prevention were systematically delayed before each new election. The 
laws forbidding condom publicity and the sale of syringes were only revised in 
1987 and 1988. When the National Front started an anti-AIDS crusade in 1986- 
87 demanding systematic screening of large parts of the population and 
quarantine for HIV carriers, protest arose from all political parties, the 
intellectuals and the press. The common political response was "the defence of 
freedom" and "the fight against discrimination", the National Front finally 
withdrew from the unfruitful subject but the arguments shaped the subsequent 
public AIDS campaigns. When the French Agency for AIDS Prevention was 
finally set up in 1989, messages focused on "solidarity" with the victims of the 
epidemic and on a common risk concerning "everyone". The public health risk 
was subordinated to political values. The AIDS case provided the ground on 
which the Republican principle of egalitarian treatment which excluded 
references to specific groups was demonstrated.
Private Life and Public Policy
The initial AIDS policy promoters stressed individual behaviour as a risk factor 
and the fact that the disease was not infectious like tuberculosis. The 
behavioural model, which normally refers to pathologies linked with smoking 
and alcohol consumption, was forwarded in support of the educational approach 
to exclude AIDS from the application of existing public health laws. In fact, 
AIDS corresponds with the model of sexually transmittable disease (STD). 
Sexuality belongs to private life but it has public consequences (Bayer, 1989). 
This private-public junction is common to most public health issues.
The STD model allows the main conditions of successful public health 
management to be isolated. Prevention depends on the capacity to develop 
public policies in an intermediate sphere across this public/private junction. In 
countries where the political culture imposes a clear borderline between what is 
considered as private and public, as in France, prevention policies are likely to 
meet with political resistance. Implementation is favoured in a context where 
sexuality is no longer regarded as a moral or societal issue, but as a 
responsibility for all educational authorities. Available institutional and 
professional authority can then be mobilised and oriented towards the new 
problem. Health oriented sex education in schools illustrates the case. Previous 
policies in the field of sexuality and contraception shape the range of policy 
choices and their social acceptability. Finally, since beneficiary participation 
constitutes a major element in AIDS prevention, the degree of organisation and 
the attitudes of gay communities towards health issues condition the policy 
impact.
In Italy, state intervention in the field of sexuality was delayed because 




























































































and family, a subject considered to belong under its normative authority. 
Condom promotion became a public policy only after the health minister 
changed from a Christian Democrat to a member of the Liberal Party in 1989, 
and under the pressure of the medical experts from the National AIDS 
Commission. However, public promotion of condom use and sex education in 
schools had to compromise with moral views if they were to be politically and 
socially acceptable. Public campaigns therefore insisted on "normal family life" 
(Cattacin and Panchaud, 1997).
France had a long tradition of legal prohibition on condom production, 
sale and in some periods even on use (Vidal, 1991). From the mid 1960s 
onwards, several laws were passed favouring sexual liberty. Legislation passed 
"from a post-Vichy regime to a post-68 regime", towards a model of "sexuality 
without norms" (Mossuz-Lavau, 1991). Contraception was introduced after a 
battle with left wing women’s organisations which imposed general access to 
oral contraception and abortion, free of charge (Veil Act, 1975). As a result of 
the political compromise with the conservatives, publicity for all contraceptive 
means, including condoms, was legally forbidden. The final stage in the sexual 
liberation process was the abolition of laws on homosexuality in the early 
eighties, coinciding with the outbreak of AIDS. The still badly organised gay 
community considered the risk alarm to be propaganda against their recent 
freedom. As a consequence, the first AIDS organisation, operational since 1985, 
was accepted only reluctantly among French gays. The post-1968 inheritance, 
combined with the weak position of public health experts provided uncertain 
grounds for AIDS prevention.
Britain and Germany did not need to overcome such historical handicaps. 
Britain could even rely on historical achievements. The campaigns against 
venereal disease at the end of War II provided a precedent of public condom 
promotion (Porter, 1988). Furthermore, the gay communities in the two 
countries were already well organised and even accustomed to negotiations with 
public health agencies, because of earlier initiatives aiming at improving care 
and prevention of STD (hepatitis B).
The private/public challenge resulted in different policy styles. In Great 
Britain and Germany advertisements for condom use referred directly to AIDS, 
precise risk situations and the personal responsibility of the partners. This was 
illustrated by the British slogans aiming at encouraging people to "keep to one 
partner or at least to use a condom" (Street and Weale, 1992, p. 204) and "You 
know the risk, the decision is yours", and in the German slogans: 
"Responsibility is part of it", "Our fidelity protects the two of us" and "AIDS 
does not fall on you, you catch it yourself'. French public campaigns, on the 
contrary, spelled out little as to the practical behaviour in concrete situations4 




























































































launched on a large scale from 1989 onwards, by the French Agency for AIDS 
Prevention. Messages promoted a joyful image of free sex with condoms. 
These, it was advertised, "preserve(d) from all, even from being ridiculous", and 
"wish(ed) everyone a happy holiday". The link with AIDS, illness and the fatal 
risk was deliberately not referred to, in order not to frighten the public and drive 
infected people into isolation. AIDS and HIV were only addressed in 
connection with solidarity and love, illustrated by advertisements from 1991 
where young smiling girls and boys asked in a quiet, assured manner "If I am 
HIV-positive, would you dance with me?".
The Agency was criticised for inefficiency in the Montagnier report 
(1993), and closed down in 1995. Its short and conflict laden existence 
illustrated the difficulties in the French context, of promoting prevention 
strategies across the public/private borderline. The Agency had seven directors 
in six years and suffered from continuous conflict with the private AIDS 
associations, over authority and control issues and over the content of 
prevention messages and their destination, to the general public or targeted 
groups. When AIDS prevention was transferred to the General Department of 
Health, the conflict over the models of STD prevention continued inside the gay 
associations, which were divided over their relation with the state and their 
position in society. Finally, in 1998, fifteen years after the epidemic was 
identified, the specific AIDS unit in the General Department of Health was 
transformed into a new larger division in charge of all transmittable disease. 
This transition illustrates the shift from ideological controversy to technical risk 
management. Adequate institutional support is now being provided by the new 






























































































The most exceptional element in AIDS management, compared to cost 
containment and other health policy issues, was the active implication of the 
beneficiaries. The wide range of initiatives, goals and country specific 
situations have in common the introduction of non-medical dimensions.
Participation was initiated by gay groups in order to meet the urgency and 
new needs in their own ranks. Experiments centred on group specific prevention 
campaigns aiming at new patterns of sexual behaviour (safer sex), 
psychological and social support for the ill and dying, and interest 
representation. The latter covered a wide spectrum of goals ranging from fund 
raising and improvement of medical care to ensuring access to lodgings, 
insurance coverage, employment and the provision of legal services to defend 
victims of discrimination. Haemophiliac associations focused on financial 
compensation for those infected by medically transmitted HIV. Attempts to 
extend compensation to all those infected during transfusion, notably hepatitis 
B and C which concerned not only haemophiliacs but many former patients, 
were rejected because of the financial burden. Instead, safety standards in the 
blood and plasma industry as well as in hospitals became the centre of interest.
The distinct channels of interest representation converged towards 
common goals. Pressure for resource allocation to AIDS research, care, 
prevention and compensation schemes constituted the traditional part of it. The 
innovative parts were the right to "normal life" for the chronically ill, 
comprehensive medical and social services and the legal protection of patients. 
The “normal life” issue was the main raison for the refusal of traditional public 
health methods. It also explained why haemophiliacs and their doctors had 
refused to renounce the prophylactic treatment with potentially dangerous 
clotting concentrates. The normal life argument was put forward to press for co­
ordinated care structures allowing AIDS patients to stay at home and if possible 
continue to work. In the field of psychological and social support, the 
associations acted simultaneously as voluntary structures fostering self-help and 
as private providers for public services. Private-public collaboration 
corresponded to more general reform agendas in the health sector, especially in 
the British NHS (Berridge, 1996), aiming at reducing the role of the public 
sector in the provision of services. Concerning legal protection, gay activists 
aimed at non-medical issues whilst haemophiliacs focused directly on the safety 
of medical treatment. Arguments that public authorities were responsible for 
risk management, that doctors were responsible for their prescriptions and that 
patients had to be clearly informed about potential risks were the bases for 
compensation claims. In France, where the responsibility regime for patients 




























































































legal procedures around the "contaminated blood scandal" redefined and 
reinforced the medical and public responsibility for patients.
The long term strategies of haemophiliacs and pressure groups concerned 
with AIDS are now moving in a common direction aiming at scientific 
developments and control over relevant parts of the pharmaceutical industry. 
Medical experts, themselves belonging to the gay or haemophiliac communities, 
play an important role in mediation and the transmission of knowledge. AIDS 
pressure groups watch therapeutic progress closely. They have obtained rapid 
access to new therapies, so reducing the delays for clinical trials, placebo 
methods and marketing authorisations. They lobbied governments to negotiate 
research and development, price setting and commercial strategies with the 
pharmaceutical firms. Haemophiliacs followed genetic research and the 
production of medicines to replace human blood donation by risk-free 
technology closely. They lobbied for a strategy aiming at a "zero risk" level in 
the blood banks and the plasma industry. New tests were introduced to screen 
out extremely rare risks, at huge financial expense. Cost-benefit approaches 
have limited impact on European AIDS management.
Gay and haemophiliac associations succeeded in imposing their views 
after they had shaken off medical dependency and turned towards political 
pressure and legal support. The need orientation of AIDS policies was often 
explained by the impact of gay lobbying. European comparison however 
suggests that it is more likely to be explained by institutional characteristics. 
Germany provides the best example of sustainable participation, developed in 
line with the model of co-management in the health sector and implemented as 
part of the official principle of subsidiarity. In this model, common policy goals 
were limited to health protection, excluding gay identity issues (Buchow, 1997; 
Rosenbrock, 1994). In the British NHS context, voluntary organisations became 
a policy relay to ensure the implementation of the public policies in gay or IDU 
communities (Berridge, 1996), whilst Italian gay groups, although they 
promoted rather efficient prevention campaigns in their own ranks, obtained 
only limited access to local policy networks in northern towns. In France, open 
conflict with beneficiaries, gay activists as well as with haemophiliacs and 
blood transfusion victims, illustrated and challenged the corporatist model of 
governance in the health sector which was particularly resistant to beneficiary 
participation (Steffen, 1997). The AIDS epidemic opened a breach in medical 
leadership. Participation extended well beyond the traditional limits of patients’ 
associations dominated by doctors, because it addressed non-medical issues and 




























































































INTRODUCING HEALTH DIMENSIONS IN PUBLIC POLICIES
Introducing a public health approach into drug policies and the blood banks was 
a major challenge for AIDS prevention. Whilst safer sex could be viewed as a 
matter of individual choice and education, prevention in these two fields 
depended on public and professional intervention. Policy priorities had to be 
revised and institutional changes introduced. Previously, drug policies had been 
considered from a public security perspective, with path dependency reaching 
back to the ways youth and urban problems were dealt with. Blood collection 
was viewed as part of the medical system serving individual patients, with an 
emphasis on sufficient supply and voluntary donation. In these fields of drug 
abuse and the therapeutic use of blood products, problem framing had to shift 
from social philosophies towards the management of the public health risks.
Risk reduction for drug addicts
The evidence which had accumulated since 1982-83, showed that disease 
transmission spread among drug users through needle sharing. The educational 
approach of prevention could only be effective if clean injection equipment was 
provided on a large scale, through free sale in chemist’s shops and vending 
machines, free distribution in medical or social services, and through needle 
exchange programmes. These consisted in the provision of disinfecting kits or 
the exchange of a clean syringe for a used one, and were particularly relevant 
because this method fostered regular contact with the addicts which provided a 
framework for educational intervention. Also, medical care had to be offered to 
addicts because, a part from the medical benefits, relief from suffering 
constituted a powerful incentive for socially marginalised people to frequent the 
services and develop health awareness. Repressive policies which penalised 
drug consumption and drove addicts underground, had to be revised if the new 
strategies were to be implemented. AIDS policy makers and pressure groups, 
therefore, focused on law as the central prevention factor.
However, comparison showed that public health strategies depended less 
on law than on the institutional capacities of co-ordination between medical and 
social services. Britain and Italy shared a liberal legislation towards drug 
consumption whilst Germany and France had a similar legal context of 
prohibition. Yet, in 19986 , AIDS prevalence due to intravenous drug injection 
was still much higher in Italy than in Great Britain, although it was estimated 
that prevention messages were more widely diffused among Italian addicts7, and 
higher in France than in Germany although addiction was estimated much 
"stronger" in Germany8. The law remained unchanged, but practical changes 
took place in Germany much earlier and on a broader scale than in France. Path 




























































































shaping problem framing and decision making determined the national 
capacities to respond to the new public health challenge.
Before AIDS was known, "harm reduction strategies" had already 
emerged in Britain, in local initiatives which had brought together voluntary 
organisations and social services (Berridge, 1993). They aimed at reducing the 
social consequences of addiction, such as marginalisation and delinquency. 
With AIDS, these networks reoriented their activity toward "health risk 
reduction”. Needle exchange programmes and comprehensive primary care for 
addicts had been launched, by in the mid-eighties, under the responsibility of 
the local NHS units and with national support. The autonomy of Scottish health 
authorities, which had hesitated to implement the new strategies, brought about 
considerable local differences in policy content and results. Whilst nearly half 
of the IDUs in Edinburgh were HIV-infected, transmission remained an 
exceptional accident in Manchester and Liverpool9.
In Italy, favourable general conditions, including easy access to low cost 
syringes and intervention strategies maintaining the social integration of 
addicts, did not compensate for the lack of co-ordination between separate 
policy networks, at national and local levels. The surveillance and management 
of addiction was partly given over to private associations, which run many of 
the famous therapeutic communities. The care institutions linked with local 
governments and the political Left promoted the new risk reduction strategies, 
including needle provision and methadone treatment. Those linked with 
Catholic organisations tried to maintain their traditional commitment to 
abstinence goals, in the fields of addiction as well as sexuality. The gap resulted 
in unclear and even contradictory messages being delivered to people at risk, a 
factor found to be highly counterproductive for behavioural changes in recent 
AIDS research (Campenhoudt et al., 1997). Coherent prevention strategies 
depended on isolated local circumstances, found in Bologna and Modena 
(Cattacin, Lucas and Vetter, 1996).
In Germany, health risk reduction was implemented under pressure from 
professionals in the drug as well as the public health field. They were supported 
by the health ministers but, in the case of treatment of addicts with methadone, 
they encountered strong opposition from the national medical commission 
responsible for clinical classifications of medicines. This resistance was 
overcome by reform dynamics originating from the regions. Left governed 
regions and large cities launched methadone programmes under their own 
authority, as part of their general anti-AIDS programme. When opponents 
turned to the courts, jurisprudence established that legal restriction did not 
apply to public health goals. Subsequently, the sickness funds supported the 
programmes financially, because they estimated that methadone provision to 




























































































cases. The various components of IDU/AIDS prevention were adapted to local 
needs, with an emphasis on street work, under the authority of the public health 
offices (Gesundheitsamter), each of them staffed, for at least five years (1988- 
93), with a co-ordinator for AIDS prevention. j
In France, risk reduction met with twofold political and professional 
opposition which was not compensated for by the weak public health experts or 
by organised social demands. Although the sale of syringes was allowed from 
1987 onwards, the police continued to arrest addicts, especially near chemist 
shops. Syringe possession continued to be officially considered as an "indicator 
of illegal consumption". The professionals caring for drug addicts, affiliated to 
a single national association, were committed to the psychoanalytical paradigm 
using abstinence as a sign of personality change (Bergeron, 1998). Until the 
early nineties, professionals refused to accept the AIDS risk, in order to prevent 
the "re-medicalisation of their sector (interview)" and escape from medical 
authority. When growing numbers of addicts arrived in hospital services and the 
staff were confronted with behavioural problems, the General Department of 
Health organised joint training sessions, from 1988 onwards, for medical staff 
and professionals from the drug sector in order to foster mutual understanding. 
Risk reduction strategies were first launched by a humanitarian medical 
association which operated the first mobile street unit, with a modest funding 
from the ministry. Greater awareness for necessary changes grew only in the 
aftermath of the contaminated blood trial, towards the mid-nineties. The 
Henrion Commission (1995) introduced, for the first time, experts from fields 
outside the narrow corporatist network. Tension then arose between general 
practitioners, hospitals and the drug caring services over the question of who 
should be authorised to prescribe substitutive medication. However, pragmatic 
changes slowly followed. At the end of 1996, some 300 places for methadone 
treatment were operational, compared to 15-17,000 in Germany, Britain and 
Italy.
AIDS prevention for drug addicts also entailed national inquiries into 
health conditions and disease transmission in prisons. In most European 
countries, efforts have been made to improve health protection and medical care 
for inmates, in order to prevent disease transmission when they return to normal 
life. A European network is now operating, funded by the European 
Commission and specialising in sexually transmittable and infectious diseases 
linked with imprisonment10. AIDS prevention in prisons illustrates the broader 
issue of public health management in marginalised populations, developing 
outside the traditional sphere of the welfare state, in connection with the 




























































































Risk management in the blood transfusion sector
Public health decisions had to be made in uncertain circumstances. Experts 
were divided over risk evaluation. Despite growing evidence of the fatal issue 
which was confirmed in 1984, many experts maintained the hypothesis that a 
positive antibody test indicated immunity against the virus. It was thought that 
only 10% of HIV-infected people would develop AIDS. Furthermore, it was not 
always clear who was responsible for blood security. In France, governance 
problems extended to a point when fifteen years after the facts, in early 1999, 
three former ministers were tried for their inappropriate action at the time, and a 
further criminal trial of thirty medical specialists and government advisers is 
still to take place. All this followed the conviction of four top executives of the 
transfusion and plasma system in 1991-92.
The overall challenge was to introduce a serious selection of blood 
donors (to be extended to all organ, sperm and cell donation), systematic 
screening of the blood samples and virus inactivated medicine for 
haemophiliacs. Crisis management proved more or less difficult in the national 
transfusion systems, according to their cultural inheritance and co-ordination 
capacities. Donor selection depended on professional paradigms and practice; 
the systematic screening of blood samples on provision of finance; access to 
purified clotting concentrates on the information and the effective freedom of 
prescription of the clinicians; reduction of blood transfusions in hospitals and 
clotting concentrates in haemophilia treatment on individual medical decisions 
and the collective attitude of the haemophilia establishment.
In most countries, haemophiliacs refused to go back to former treatment 
and pushed for access to the new virus-inactivated medication which was 
available on the international market from the end of the seventies. The higher 
costs had to be negotiated with the health insurance funds. In France however, 
an unwritten rule of national self-sufficiency opposed importation. National 
production of clotting concentrates started in 1981 and was fully operating in 
1984, coinciding with the spread of the epidemic. Technological choices had far 
reaching consequences. The new production units were set up without an 
inactivation process and technical difficulties arose when inactivation 
techniques had to be integrated into French production methods. This was 
finally achieved in the autumn 1985. The unwritten rule of protectionism 
originated from two sources: an ethical conviction which had prevailed since 
the early fifties, according to which blood security was based on voluntary 
donation in line with the Titmuss model (1970), and economic priorities 
adopted in the early eighties, according to which the biomedical industry was to 
be developed both for employment and export. With the approach of the free 
European market for pharmaceutical products, was approaching, in the mid­




























































































Although the screening of all blood samples was adopted relatively early 
in France (1st August 1985), legal investigation established that the official 
decision should have been taken earlier, and that it had been delayed for at least 
three months, in order to preserve the domestic market from international 
competition with the American Abbott test. Cost containment aims in health 
insurance also added to the delays. Initially, no provision was made for free 
access to HIV-testing apart from blood donation. People at risk used the blood 
banks to obtain information on their serological status. Tests prescribed by 
doctors were only reimbursed from February 1986 and anonymous centres for 
free testing were only set up in late 1987.
Donor selection started in most countries with an official request 
addressed to identified risk groups to abstain from blood donation. Furthermore, 
a questionnaire had to be answered by each donor on his individual behaviour 
and risk factors (Feldman and Bayer, 1999). The French authorities followed 
opposition from the gay representatives, the intellectuals and the media against 
the designation of risk "groups", which it was thought, would lead to 
stigmatisation. At the same time, blood donor associations and the blood centres 
refused to question donors about their "private life", considering it a moral 
offence. When the General Department of Health released an official directive 
in June 1983, ordering the blood centres to reinforce donor selection, it was 
simply ignored. Furthermore, the need for blood had grown rapidly as the 
national production of clotting concentrates had developed. To meet the 
demand, collections were organised in streets of red light districts and in 
prisons. In early 1985, the department of prison administration called for more 
blood collection in prisons, which was considered as part of the social 
reinsertion of prisoners. This risky collection represented less than half a 
percent of the total volume of donated blood but caused 30% of contaminations 
(IGASS/IGSJ, 1992).
Public health management in France was confronted with a specific 
combination of symbolic values and economic interests (Steffen, 1999a). The 
over-valuation of blood donors which made donor selection very difficult was 
linked with a World War II and Liberation bom ideology assimilating blood 
donation to a heroic act of national solidarity and independence (Hermitte, 
1996). Social beliefs contributed to the "sinistre exception française" (Morelle, 
1996, 24-27), totaling 60 % of all HIV-infection transmitted by blood 
transfusion in the twelve countries of the European Union. In Britain, where the 
blood transfusion system operated within the NHS, donor selection was 
reinforced immediately when the new risk was known. In Germany, the Red 
Cross in collaboration with the medical experts of the public health institutions 
led the way. In Italy, the blood banks took local initiatives, more or less co­




























































































Health ministry finally established a list of groups to be excluded from blood 
donation, with the risk of legal pursuit if it was not respected.
The contamination of haemophiliacs was similar in countries where 
access to the new clotting factors was granted. The French public system did 
not manage to protect its patients any better than the international private 
companies which where operating on the European market.
Table 4 . Blood transfusion and haemophilia treatment
France Italy Germany GB
Recorded AIDS cases, 
31 Dec. 1998 :
- haemophiliacs 582 332 542 640
- transfusion recipients 1,734 384 266 133
Total HIV cases (estimates) >4,000 <1,200 <1,100 <800
Contamination rate 
among haemophiliacs 45 % 23% 46% 48 %
HTV-positive donations 
per 100,000 :
1986 40.6 27.6 4.2 2.0
1991 7.9 6.0 2.3 0.9
1997 2.2 2.7 1.2 1.1
Sources: The European Epidemiological Surveillance Center for AIDS, 
EU-WHO, Paris (Quarterly Reports). Koch E.R. (1992), Heine, W.G. (1993).
The institutional characteristics of the French system rendered policy and 
decision making very difficult. The industrial plasma sector developed as part 
of traditional blood transfusion activities, without an institutional reform to 
ensure adequate control procedures (Setbon, 1993). The central health 
administration depended on national expert commissions for information and 
advice but had no effective control over the sector. The blood banks were 
largely autonomous since they were placed under the authority of a medical 
director entitled like all doctors to professional autonomy. This led to confusion 
in the perception of legal responsibility (Hermitte, 1996) which was seen as 
belonging to the regimes of medical and public service responsibility. These 
were both under obligation to provide equal access to services but were not 
subject to product liability11. Furthermore, little connection existed between the 
blood banks and the hospitals. Transfusion transmitted disease, therefore, went 
largely unnoticed (IGASS/1GSJ, 1992). It was only in the aftermath of the HIV- 
contamination that systematic follow-up systems was established enabling each 




























































































patient destination to be kept. The 1993 reform restructured the entire blood and 
plasma sector which is now effectively controlled by the health authorities, 
advised by independent commissions. Blood products integrated the status and 
the surveillance procedures for pharmaceutical products, which were also 
reformed and reinforced.
AIDS management favoured the rationalisation of professional pratice 
and public intervention in both sectors, in the field of drug policies and the 
blood transfusion industries. It led to the harmonisation of safety standards, the 
reinforcement of public and medical responsibility for potential risks and the 
recognition of the rights of patients, regardless of specific medical "errors". The 
changes were naturally most important in France 2 where incremental change 
proved most difficult because of corporatist policy patterns.
PUBLIC HEALTH DYNAMICS, MEDICAL PROGRESS AND 
CHRONIC DISEASE
Finally, what was so new about AIDS? Most of the innovations developed to 
meet the challenge already existed. Therapeutic apartments had been set up as 
part of psychological care. Self-support and self-help organisations had 
operated in various fields in Germany, Holland and elsewhere. Social and 
psychological support had already been developed to cope with alcoholism, 
drug abuse and chronic disease. Patients’ associations already existed for cancer 
and other chronic pathologies. As with donor selection, harm reduction of drug 
abuse and the public promotion of condoms, all these elements had been 
experimented with before. Their simultaneous application in a unique case 
however was new. Under the threat of an international public health 
catastrophe, these elements formed a coherent dynamic in which public health 
moved from the periphery of the medical system to the centre of political 
attention. This is easily illustrated by the example of sexual health. Public 
intervention in the field of sexuality became legitimate when oriented towards 
the protection of public health. Although to varying degrees, health oriented 
sexual education was introduced in normal school programmes. In Germany 
"sexual pedagogy" became a new university discipline, based on knowledge and 
theories largely drawn from the experience acquired with AIDS (Sielert, 1995).
The public health dynamic was amplified at the European level. Initially, 
as in most health issues, European implication was limited, to some co­
ordination between loose networks of a medical and scientific nature on the one 
hand and activist initiatives on the other (Altenstetter, 1994). Closer integration 
was achieved through the European anti-AIDS programmes which structured 
research and introduced a comparative evaluation of different intervention 




























































































surveillance systems and expertise capacity, focusing on the harmonisation of 
statistical data and, as a second step, in policy tools and goals. This 
development is well illustrated by the European Agency for anti-drug policies. 
The blood transfusion issue contributed to the harmonisation of security 
standards and the marketing authorisation for plasma products, now placed 
under the newly created European Agency for pharmaceuticals. The AIDS 
programme extended to cover all transmittable disease, with a focus on trans­
national problems. AIDS helped to initiate European public health policies, 
compensating for the lack of authority over the organisation and financing of 
medical care systems which have remained under national control.
The common direction between AIDS fostered innovations and general 
reforms in the health sector was also new. AIDS management favoured the 
restructuring and rationalisation of services, in line with cost containment. 
Three specific aspects are to be mentioned here. Firstly, the rapid progress in 
therapy, combined with the pressure for access from mobilised patients, led to 
standardised treatment protocols and the strict surveillance of medicine 
delivery. In AIDS treatment, the doctors’ freedom of prescription was severely 
limited, which contributes to the general trend towards the evaluation of 
medical activity. Secondly, medical care for AIDS patients fostered 
comprehensive service structures combining hospital and home care, a 
particularly difficult issue in many European health systems. Until very 
recently, the pathology ' has evolved with alternate phases of acute life 
threatening illness and remissions allowing home care. Cost containment and 
the patients’ demand for "normal life" created a common pressure for closer 
service co-ordination. Thirdly, the contamination of blood banks, the discovery 
of growing risk of disease transmission in hospitals and the development of 
antibiotic-resistant pathogens made hospital hygiene a new priority and new 
task for hospital management. Reinforced control over medical activities and 
the legal protection of patients, have contributed to breaking the monopoly of 
the medical profession.
Future developments and perspectives are dominated by the new 
therapeutic progress. The recently introduced multi-therapies reduce the viral 
charge in the infected body. Patients now rarely die, they recover to nearly 
normal health. The heavy treatment is most efficient when started in the early 
stage of infection. People at risk now have a direct therapeutic interest in being 
HIV-tested after each risk exposure. Consequently, a growing number of people 
are under medical treatment and surveillance for life. The new treatment moves 
AIDS into the category of chronic disease. Yet there are important differences 
compared to other chronic diseases. The patients are young, of working age, and 
they remain infectious. The main motivation for individual behavioural 
changes, however, faded with the perspective of possible survival and recovery. 




























































































secondary consequences have appeared, individual resistance to the treatment is 
growing and, most of all, multi-resistant viruses have already developed within 
less than two years, a phenomenon observed with antibiotics which took thirty 
years. This gives a view over the lasting scientific, medical and social 
challenge.
The recent developments signify, in addition to growing budget 
allocation, the necessity to organise long term medical monitoring of growing 
numbers of patients and, simultaneously, to maintain and reinforce prevention 
strategies. Unlike previous transmittable diseases but similar to chronic disease 
and age related pathology, the responsibility of public health authorities in the 
case of AIDS is not diminishing but growing with therapeutic success.
CONCLUSION
Management of the AIDS epidemic has offered an occasion to observe health 
systems in a transversal perspective. It has revealed their capacity to respond to 
new issues and their interaction with broader policy networks and social 
demands. The health systems examined here have faced a multi-fold challenge: 
the introduction of non medical intervention strategies, co-ordination of several 
policy sectors, beneficiary participation and public health management, the 
latter extending over the control of infectious disease and health protection in 
underprivileged populations. All finally adopted similar policies, but by 
different ways and with different timing, according to their institutional 
capacities and models of change.
The policy responses to the public health challenge indicated Northern 
and Southern models, which may suggest different hypotheses. To what extent 
is public health management related to cultural influences? How is it related to 
the organisational features of the welfare states? The comparative results 
suggest the following conclusions:
In the public health field, cultural values act via risk perception, the social 
attitude towards sexuality and marginal behaviour, and the public/private 
borderline. They condition the content of what is considered to be a personal or 
state responsibility in health protection.
Welfare states focused on the development of the medical care system. 
Public health remained a weakly structured field where cultural references and 
political attitudes maintained influence over public choices and professional 
practice. When policies have to be developed in this marginal field, then 
integrated health systems such as the British and Scandinavian models tend to 




























































































development of activities, an organisation which favours links between care and 
prevention, and a joint responsability over hospital and primary care structures.
Public health policies are not cost saving. The global cost of efficient 
AIDS management, including the budgets for research, prevention, care, and the 
provision for "normal life" conditions represent a heavy charge inside and 
outside the health systems. The generalising trends of AIDS management are 
essentially linked with breaking the medical power over health issues. Law 
courts have played a role in the protection of patients, and doctors have 
accepted limitations in their freedom of prescription and medical decision 
making which they had refused in both other medical fields and cost 
containment.
The combined pressure of cost containment and public health 
management fosters a new model of health protection within European welfare 
states, aiming at greater global efficiency. The European level constitutes a 
strategic lever in this reorientation. Whether the tendency will help to narrow 
the gap between Northern and Southern European health systems remains an 
open question.
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8 In 1991, 2,125 deaths from overdose were recorded in Germany ; compared to
a hundred cases recorded in France and 465 in 1995 (Sources : BKA Report 
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